DK1326592T3 - Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse - Google Patents

Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse

Info

Publication number
DK1326592T3
DK1326592T3 DK01975466T DK01975466T DK1326592T3 DK 1326592 T3 DK1326592 T3 DK 1326592T3 DK 01975466 T DK01975466 T DK 01975466T DK 01975466 T DK01975466 T DK 01975466T DK 1326592 T3 DK1326592 T3 DK 1326592T3
Authority
DK
Denmark
Prior art keywords
peg
polyethylene glycol
constipation
drug
manufacture
Prior art date
Application number
DK01975466T
Other languages
English (en)
Inventor
Russell W Pelham
Mark Vb Cleveland
Original Assignee
Braintree Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braintree Lab filed Critical Braintree Lab
Application granted granted Critical
Publication of DK1326592T3 publication Critical patent/DK1326592T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
DK01975466T 2000-09-28 2001-09-27 Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse DK1326592T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/675,105 US6645481B1 (en) 2000-09-28 2000-09-28 Method of achieving overnight laxation and control of bowel function
PCT/US2001/030227 WO2002026222A2 (en) 2000-09-28 2001-09-27 Method of achieving overnight laxation and control of bowel function

Publications (1)

Publication Number Publication Date
DK1326592T3 true DK1326592T3 (da) 2008-11-10

Family

ID=24709076

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01975466T DK1326592T3 (da) 2000-09-28 2001-09-27 Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse

Country Status (12)

Country Link
US (1) US6645481B1 (da)
EP (1) EP1326592B1 (da)
AT (1) ATE401900T1 (da)
AU (1) AU2001294790A1 (da)
CA (1) CA2423746A1 (da)
CY (1) CY1110052T1 (da)
DE (1) DE60135001D1 (da)
DK (1) DK1326592T3 (da)
ES (1) ES2310190T3 (da)
PT (1) PT1326592E (da)
SI (1) SI1326592T1 (da)
WO (1) WO2002026222A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
CA2546019A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
US20050244368A1 (en) * 2004-04-29 2005-11-03 Pashankar Dinesh S Pre-endoscopic use of polyethylene glycol compositions
US20060247180A1 (en) * 2005-04-29 2006-11-02 Bergey James L Purgative composition and uses thereof
WO2006118562A1 (en) * 2005-04-29 2006-11-09 Inkine Pharmaceutical Company, Inc. Purgative composition and uses thereof
US7495063B2 (en) * 2006-02-03 2009-02-24 Dow Global Technologies Inc. Reduced oligomer concentration in high purity polyalkylene glycols
CN105142617B (zh) 2013-03-15 2018-08-03 布伦特里实验室公司 双用途硫酸盐口服药物组合物片剂及其使用方法
AU2015253178B2 (en) 2014-04-29 2020-03-12 Colonaryconcepts Llc Foods, systems, methods, and kits for providing electrolyte replacement
JP6516859B2 (ja) 2015-03-02 2019-05-22 コロナリーコンセプツ エルエルシー Ｐｅｇ代謝物及びｐｅｇ分解生成物のアッセイのための化合物並びに方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation

Also Published As

Publication number Publication date
WO2002026222A2 (en) 2002-04-04
US6645481B1 (en) 2003-11-11
EP1326592B1 (en) 2008-07-23
ES2310190T3 (es) 2009-01-01
DE60135001D1 (de) 2008-09-04
ATE401900T1 (de) 2008-08-15
EP1326592A1 (en) 2003-07-16
CA2423746A1 (en) 2002-04-04
WO2002026222A8 (en) 2002-06-27
CY1110052T1 (el) 2015-01-14
SI1326592T1 (sl) 2009-02-28
AU2001294790A1 (en) 2002-04-08
PT1326592E (pt) 2008-10-20

Similar Documents

Publication Publication Date Title
CY1110052T1 (el) Η χρηση της πολυαιθυλενογλυκολης (peg) για την κατασκευη φαρμακου για τη θεραπεια της δυσκοιλιοτητας
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
BR0109943A (pt) Composições farmacêuticas
DK1157037T3 (da) GCSF-konjugater
DK1257254T3 (da) Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
ATE411007T1 (de) Gegen missbrauch gesicherte darreichungsform
NO972324D0 (no) Orale blandinger inneholdende Ondansetron
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
EP1048297A3 (en) Use of polyethylene glycol for reducing of intestinal gas, cramping and anorectal irritation
SE0101932D0 (sv) Pharmaceutical combinations
WO2002048141A1 (en) Medicinal compositions improved in solublity in water
ATE243196T1 (de) Piperidine und pyrrolidine
DE60239752D1 (de) Den geschmack verdeckende auslaufsichere formulierung
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
DK1559431T3 (da) Farmaceutisk sammensætning til thrombinpeptidderivater
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
MA22343A1 (fr) Compositions type massepain, contenant du psyllium
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
PT1250125E (pt) Composicoes farmaceuticas contendo terbinafina